Healthcare provider profile · identity verified

Timothy Blackner

Family Practice · FLORENCE, SC · NPI 1245790302

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	397	128
Amlodipine Besylate	Amlodipine Besylate	272	85
Lisinopril	Lisinopril	244	78
Losartan Potassium	Losartan Potassium	215	76
Levothyroxine Sodium	Levothyroxine Sodium	212	65
Gabapentin	Gabapentin	190	52
Omeprazole	Omeprazole	189	55
Tamsulosin Hcl	Tamsulosin Hcl	175	44
Trazodone Hcl	Trazodone Hcl	147	44
Hydrochlorothiazide	Hydrochlorothiazide	135	49
Metoprolol Succinate	Metoprolol Succinate	130	41
Ozempic	Semaglutide	103	28
Pantoprazole Sodium	Pantoprazole Sodium	99	29
Rosuvastatin Calcium	Rosuvastatin Calcium	97	35
Albuterol Sulfate Hfa	Albuterol Sulfate	94	37
Potassium Chloride	Potassium Chloride	85	22
Metformin Hcl	Metformin Hcl	80	26
Furosemide	Furosemide	78	30
Montelukast Sodium	Montelukast Sodium	78	23
Sertraline Hcl	Sertraline Hcl	77	21
Tramadol Hcl	Tramadol Hcl	74	25
Metformin Hcl Er	Metformin Hcl	73	25
Bupropion Xl	Bupropion Hcl	69	21
Eliquis	Apixaban	69	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	30
Simvastatin	Simvastatin	64	21
Carvedilol	Carvedilol	62	17
Citalopram Hbr	Citalopram Hydrobromide	62	19
Duloxetine Hcl	Duloxetine Hcl	61	18
Spironolactone	Spironolactone	61	19
Escitalopram Oxalate	Escitalopram Oxalate	55	18
Quetiapine Fumarate	Quetiapine Fumarate	54	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	15
Fluticasone Propionate	Fluticasone Propionate	50	20
Pravastatin Sodium	Pravastatin Sodium	50	16
Fluoxetine Hcl	Fluoxetine Hcl	47	15
Jardiance	Empagliflozin	46	18
Naproxen	Naproxen	45	22
Allopurinol	Allopurinol	44	14
Famotidine	Famotidine	44	14
Finasteride	Finasteride	40	12
Ondansetron Odt	Ondansetron	40	19
Atenolol	Atenolol	37	13
Oxybutynin Chloride Er	Oxybutynin Chloride	37	11
Buspirone Hcl	Buspirone Hcl	36	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	11
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Prednisone	Prednisone	31	26
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Glipizide	Glipizide	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Baclofen	Baclofen	23	suppressed
Diazepam	Diazepam	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Ketoconazole	Ketoconazole	22	12
Xarelto	Rivaroxaban	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Zenpep	Lipase/Protease/Amylase	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Invokana	Canagliflozin	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Digoxin	Digoxin	13	suppressed
Fluconazole	Fluconazole	13	12
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error